Needham & Company LLC Reiterates Buy Rating for Axsome Therapeutics (NASDAQ:AXSM)
otakuyassine3@gmail.com Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment...
Axsome Therapeutics
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $200.00
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its price objective increased by HC Wainwright from...